We’re proud to share the launch of EARLYSCAN, a new European cluster uniting three Horizon Europe projects: SHIELD, DISARM, and PREDI-LYNCH, under the EU Mission on Cancer.

EARLYSCAN brings projects together to align clinical pathways, data standards, and implementation practices — moving from isolated innovation to coordinated, real-world impact.

Read the press release: https://martel-innovate.prowly.com/445670-new-european-project-cluster-earlyscan-launched-to-advance-early-detection-of-heritable-cancers?preview=true

#EARLYSCAN #SHIELD #EarlyDetection #HereditaryCancer

🚀 We’re live!
The SHIELD project website is now online: https://missionshield.eu

Stay tuned! Exciting updates, results, and events are coming soon!

🔦 Partner Spotlight: DEXAI – Artificial Ethics

At SHIELD, we partner with leaders in responsible tech. DEXAI, founded in Rome in 2021, brings deep ethical, legal & technical insight to AI development.

In SHIELD, they ensure:
🔐 GDPR-compliant data protection
🧪 Ethical oversight for research
⚙️ Ethics-by-design in AI systems

Grateful for their role in shaping safe, human-centered innovation!
#AIethics #SHIELDproject #ResponsibleAI #HorizonEU

We’re proud to spotlight Reccan AB, a Sweden-based biotechnology company and a core partner in the SHIELD project. Reccan is pioneering the development of diagnostic tools for early cancer detection, with a strong focus on pancreatic ductal adenocarcinoma (PDAC), one of Europe’s deadliest cancers.

Reccan’s work is central to SHIELD’s mission to redefine cancer screening and prevention in Europe.

#SHIELDProject #EarlyDetection #CancerDiagnostics #PancreaticCancer #HealthInnovation

Pancreatic cancer: often diagnosed too late due to lack of early detection & costly imaging.

SHIELD is changing this! We're piloting an early detection program across 7 EU countries.

Our Goal: To be fully operational in Greece, Slovenia, and Lithuania in 2 years, monitoring 5,000 individuals.

Join us in the fight for earlier detection!

#SHIELD #PancreaticCancer #EarlyDetection #HealthcareInnovation #EU

Pancreatic cancer stands as a formidable global health challenge, notorious for its aggressive nature and devastatingly poor prognosis.

🚀 It is against this challenging backdrop that the SHIELD project was established. We are a Horizon Europe initiative committed to revolutionizing the fight against pancreatic cancer through early detection and innovative strategies to improve patient outcomes and increase survival rates.

🚀 SHIELD Technical Face-to-Face Meeting in Athens – Hosted by Netcompany!

🗓️ July 15, 2025
📍 Netcompany’s Orbit Offices, Athens

Yesterday, Netcompany welcomed core technical partners of the SHIELD project for a productive face-to-face session focused on aligning progress and planning next steps across key technical areas of the SHIELD platform. A big thank you to all partners for the productive discussions, and to Netcompany for hosting us in Athens!